NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 4, 2007, Pages

  Siragy, Helmy M ^a   Inagami, Tadashi ^b   Carey, Robert M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT1 receptor; Nitric oxide; Valsartan

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RENIN; SODIUM ION; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL FLUID; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM DEPLETION; SODIUM INTAKE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CYCLIC GMP; GENE EXPRESSION REGULATION; KIDNEY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN; RNA, MESSENGER; SODIUM;

EID: 35148824109     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00014.2007     Document Type: Article

References (31)

1. Beierwaltes WH. Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol Renal Fluid Electrolyte Physiol 269: F134-F139, 1995.
2. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643-648, 1998.
3. De Gasparo M, Whitebread S, Bottari SP, Levens N. Heterogeneity of the angiotensin receptor subtypes. In: Medicine Chemistry of the renin Angiotensin Receptor Subtypes, edited by Timmermans PB and Wexler RR. Lausanne, France: Elsevier, 1994, p. 269.
4. Delacretaz E, Zanchi A, Nussberger J, Hayoz D, Aubert JF, Brunner HR, Waeber B. Chronic nitric oxide synthase inhibition and carotid artery distensibility in renal hypertensive rats. Hypertension 26: 332-336, 1995.
5. Elsner D, Muntze A, Kromer EP, Riegger GA. Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Am J Hypertens 5: 287-291, 1992.
6. Greenberg SG, He XR, Schnermann JB, Briggs JP. Effect of nitric oxide on renin secretion. I. Studies in isolated juxtaglomerular cells. Am J Physiol Renal Fluid Electrolyte Physiol 268: F948-F952, 1995.
7. Haynes WG, Hand MF, Dockrell ME, Eadingtion DW, Lee MR, Hussein Z, Benjamin N, Webb DJ. Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol Renal Physiol 272: F364-F371, 1997.
8. Henrich WL, McAllister EA, Smith PB, Campbell WB. Guanosine 3′, 5′-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol Renal Fluid Electrolyte Physiol 255: F474-F478, 1988.
9. Jin XH, Siragy HM, Carey RM. Renal interstitial cGMP mediates natriuresis by direct tubule mechanism. Hypertension 38: 309-316, 2001.
10. Kataoka H, Otsuka F, Ogura T, Yamauchi T, Kishida M, Takahashi M, Mimura Y, Makino H. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats. Am J Hypertens 14: 276-285, 2001.
11. Knoblich PR, Freeman RH, Villarreal D. Pressure-dependent renin release during chronic blockade of nitric oxide synthase. Hypertension 28: 738-742, 1996.
12. Kurtz A, Della Bruna R, Pfeilschiftet J, Taugner R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci USA 83: 4769-4773, 1986.
13. Kurtz A, Götz KH, Hamann M, Wagner C. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3. Proc Natl Acad Sci USA 95: 4743-4747, 1998.
14. Kurtz A, Wagner C. Regulation of renin secretion by angiotensin II-AT1 receptors. J Am Soc Nephrol Suppl 11: S162-S168, 1999.
15. Navarro J, Sanchez A, Saiz J, Ruilope LM, Garciaestan J, Romero JC, Moncada S, Lahera V. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol Regul Integr Comp Physiol 267: R1516-R1521, 1994.
16. Noble AR, Abu-Kishk RA, D'Aloia MA, Williams BC, Lush DJ. Cyclic GMP-linked pathway for renin secretion. Kidney Int 64: 1588-1590, 1994.
17. Ozono R, Wang ZQ, Moore AF, Siragy HM, Carey RM. Expression of subtype-2 (AT2) angiotensin receptor protein in the rat kidney. Hypertension 30: 1238-1246, 1997.
18. Reid IA, Chiu YJ. Nitric oxide and the control of renin secretion. Fundam Clin Pharmacol 9: 309-323, 1995.
19. Romero JC, Lahera V, Salom MG, Biondi ML. Role of the endothelium-dependent relaxing factor nitric oxide in renal function. J Am Soc Nephrol 2: 1371-1387, 1992.
20. Schnackenberg CG, Tabor BL, Strong MH, Granger JP. Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism. Am J Physiol Regul Integr Comp Physiol 272: R879-R886, 1997.
21. Schricker K, Kurtz A. Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol Renal Fluid Electrolyte Physiol 265: F180-F186, 1993.
22. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc Nat Acad Sci USA 93: 13176-13181, 1996.
23. Siragy HM, Carey RM. The subtype-2 (AT2) receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
24. 2 production in conscious rats. J Clin Invest 97: 1978-1982, 1996.
25. Siragy HM, de Gasparo M, Carey RM. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 35: 1074-1077, 2000.
26. Siragy HM, Howell N, Ragsade NV, Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25: 1021-1024, 1995.
27. Siragy HM, Xue C, Abadir P, Carey RM. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 45: 133-137, 2005.
28. Siragy HM. AT1 and AT2 receptor in the kidney: role in health and disease. Semin Nephrol 24: 93-100, 2004.
29. Solhaug MJ, Wallace MR, Granger JP. Nitric oxide and angiotensin II regulation of renal hemodynamics in the developing piglet. Pediatr Res 39: 527-533, 1996.
30. Wagner C, Pfeifer A, Ruth P, Hofmann F, Kurtz A. Role of cGMP-kinase I.I. in the control of renin secretion, and renin expression. J Clin Invest 102: 1576-1582, 1998.
31. Xue C, Siragy HM. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 46: 584-590, 2005.